MedTrace Logo

Integrating Aerobic, Respiratory, and Cognitive Training in Acute Heart Failure

NCT07447037 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-03-03

No results posted yet for this study

Summary

The purpose of this study is to investigate the impact of integrating aerobic, respiratory and cognitive training in acute heart failure.

Conditions

  • Acute Heart Failure

Interventions

OTHER

Aerobic training

Participants in the experimental group will receive arm ergometer training performed at the bedside for 10-15 minutes, twice daily, at low-to-moderate intensity corresponding to 40-50% of the age-predicted maximum heart rate, under appropriate monitoring. The intervention will be continued throughout the hospitalization period for a minimum duration of three weeks.

OTHER

Inspiratory muscle training

Participants in the experimental group will receive inspiratory muscle training using a threshold device set at 30% of maximal inspiratory pressure, performed twice daily for 15 minutes per session. The training load will be progressively increased according to patient tolerance, and the intervention will be continued throughout the hospitalization period for a minimum duration of three weeks.

OTHER

Cognitive training

Participants in the experimental group will receive computerized cognitive training consisting of 20-minute daily sessions targeting attention, memory, and problem-solving abilities. The intervention will be implemented throughout the hospitalization period and will continue for a minimum duration of three weeks.

OTHER

Conventional therapy

Participants in both groups will receive conventional therapy. The intervention will be implemented throughout the hospitalization period and will continue for a minimum duration of three weeks.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Azza Abdel Aziz, PhD · Ass. Professor, Cairo University

  • Alaa Mohamed Naguib, PhD · Lecturer, Cairo University

  • Ahmed Mohamed Abdelmegeed ElFeky · Lecturer, Misr University for science and technology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-07
Primary Completion
2026-04-22
Completion
2026-04-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07447037 on ClinicalTrials.gov